Week eight on tirzepatide and the scale stopped moving. I'd gone from 92.4 kg the morning I landed at NAIA in late October 2025 to 84.1 kg by mid-January 2026, a clean 8.3 kg in eleven weeks at 5mg weekly, sourced from Mounjaro vials at the Glorietta 4 Mercury Drug for USD 290 per box of four. Then February hit and I sat at 83.8 to 84.2 kg for three straight weekly weigh-ins. Same Sunday 9pm injection in my BGC condo, same kitchen scale, same morning fasted protocol. Flat.
I ran the diagnostic stack from the section above before touching the dose. Hi-Precision Diagnostics in Bonifacio Global City, Saturday morning walk-in, full panel for USD 95: TSH, free T4, fasting insulin, HbA1c, full lipid, IGF-1. Results back Monday: HbA1c had dropped from my October baseline of 5.6% to 5.3%, fasting insulin from 14.2 to 9.8 µU/mL, free T4 within range, IGF-1 mid-normal. Nothing flagged. The metabolic engine was responding correctly. I just wasn't in enough deficit anymore. The November-Ken eating like he was still 92 kg had become February-Ken eating like he was 84 kg, which at my reduced BMR was almost exactly maintenance.
Two changes: tracked food for a week with MyFitnessPal: confirmed I was averaging 2,180 kcal against an estimated 2,150 maintenance. Then titrated to 7.5mg the following Sunday, same Mounjaro stock from the same Glorietta 4 Mercury Drug shelf. Two weeks later weight was 82.7 kg. By April 2 it was 80.4 kg. The plateau was real but it was caloric, not pharmacologic, and the Hi-Precision panel saved me from blaming the vial when the vial was working fine. Total cost of the diagnostic detour: USD 95 and one Saturday morning.